MEDP
Medpace Holdings, Inc. · Healthcare · Medical - Diagnostics & Research
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 129 | -10 | 16.75M | $8.87B | +3 | −14 |
| Q1 2026 | 143 | -2 | 15.75M | $7.54B | +5 | −8 |
| Q4 2025 | 145 | 0 | 17.01M | $9.56B | +1 | n/a |
| Q3 2025 | 22 | 0 | 10.56M | $5.42B | +1 | −2 |
| Q2 2025 | 20 | +1 | 9.67M | $3.03B | +1 | n/a |
| Q1 2025 | 16 | -1 | 3.77M | $1.14B | n/a | −1 |
| Q4 2024 | 17 | +1 | 4.06M | $1.35B | +1 | n/a |
| Q3 2024 | 15 | -1 | 3.56M | $1.19B | n/a | −1 |
| Q2 2024 | 16 | n/a | 3.05M | $1.26B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (pasivo) | 583.68K | n/a | $240.63M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 2 | Renaissance Technologies ✦ | 443.59K | n/a | $182.69M | 0.3% | n/c | 1 | SEC ↗ |
| 3 | AQR Capital Management ✦ | 310.65K | n/a | $127.94M | 0.2% | n/c | 1 | SEC ↗ ×3 |
| 4 | Wellington Management ✦ | 305.37K | n/a | $125.77M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 5 | D. E. Shaw & Co. ✦ | 299.87K | n/a | $123.50M | 0.2% | n/c | 1 | SEC ↗ ×2 |
| 6 | Norges Bank ✦ (pasivo) | 279.58K | n/a | $115.15M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 237.35K | n/a | $97.75M | 0.1% | n/c | 1 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 154.29K | n/a | $63.54M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 9 | Two Sigma Investments ✦ | 123.80K | n/a | $50.99M | 0.1% | n/c | 1 | SEC ↗ |
| 10 | Fisher Asset Management ✦ | 116.39K | n/a | $47.93M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Millennium Management ✦ | 109.80K | n/a | $45.22M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Point72 Asset Management ✦ | 62.43K | n/a | $25.71M | 0.1% | n/c | 1 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 9.65K | n/a | $3.98M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Gotham Asset Management ✦ | 5.88K | n/a | $2.42M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Baillie Gifford ✦ | 5.40K | n/a | $2.22M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 16 | Capital World Investors ✦ | 615 | n/a | $253,288 | 0.0% | n/c | 1 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 724 tenedores, 23.89M acciones, $10.71B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer, Director, 10% owner · 21.97K acc. · $13.74M
Officer, Director, 10% owner · 26.70K acc. · $16.58M
Officer, Director, 10% owner · 2.41K acc. · $1.49M
Officer, Director, 10% owner · 154 acc. · $95,572
Officer, Director, 10% owner · 27.83K acc. · $17.29M
Officer, Director, 10% owner · 16.08K acc. · $10.11M
Officer, Director, 10% owner · 49.02K acc. · $30.79M
Officer, Director, 10% owner · 21.88K acc. · $13.64M
Officer, Director, 10% owner · 10.88K acc. · $6.75M
Officer, Director, 10% owner · 8.77K acc. · $5.45M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología
19.1% de clase · Ver presentación original ante la SEC ↗